Cytokinetics
(NASDAQ) CYTK
Cytokinetics Financials at a Glance
Market Cap
$7.60B
Revenue (TTM)
$88.04M
Net Income (TTM)
$784.96M
EPS (TTM)
$-6.53
P/E Ratio
-9.44
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$61.66
Volume
49,583
Open
$63.00
Price
$61.66
Volume
49,583
Open
$63.00
Previous Close
$61.66
Daily Range
$61.10 - $63.94
52-Week Range
$29.31 - $70.98
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$61.66
Volume
49,583
Open
$63.00
Previous Close
$61.66
Daily Range
$61.10 - $63.94
52-Week Range
$29.31 - $70.98
CYTK News
CYTK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cytokinetics
Industry
Biotechnology
Sector
Health CareEmployees
673
CEO
Robert I. Blum, MBA
Website
www.cytokinetics.comHeadquarters
South San Francisco, CA 94080, US
CYTK Financials
Key Financial Metrics (TTM)
Gross Margin
-22%
Operating Margin
-7%
Net Income Margin
-9%
Return on Equity
0%
Return on Capital
-50%
Return on Assets
-55%
Earnings Yield
-10.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.60B
Shares Outstanding
123.16M
Volume
49.58K
Short Interest
0.00%
Avg. Volume
2.00M
Financials (TTM)
Gross Profit
$77.91M
Operating Income
$612.26M
EBITDA
$775.27M
Operating Cash Flow
$510.01M
Capital Expenditure
$24.81M
Free Cash Flow
$534.82M
Cash & ST Invst.
$882.22M
Total Debt
$1.28B
Cytokinetics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.75M
+4.9%
Gross Profit
$14.89M
+119.4%
Gross Margin
83.89%
N/A
Market Cap
$7.60B
N/A
Market Cap/Employee
$15.26M
N/A
Employees
498
N/A
Net Income
$183.03M
-22.0%
EBITDA
$180.35M
-44.2%
Quarterly Fundamentals
Net Cash
$402.02M
-239.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$1.22B
+61.4%
Short Term Debt
$60.29M
+97.7%
Return on Assets
-55.10%
N/A
Return on Invested Capital
-50.10%
N/A
Free Cash Flow
$148.29M
-121.8%
Operating Cash Flow
$142.65M
-117.6%